Nitric oxide supplements are projected to keep growing for the next decade. According to IndexBox, the global market is forecast to expand at a compound annual growth rate of 5.8% from 2026 to 2035, with the market index reaching 175 by 2035, up from 100 in 2025. Growth, in other words, is the forecast — not proof that any specific product works.
That distinction matters. A market forecast describes what people are buying and why sellers expect them to keep buying. It does not evaluate efficacy. This guide separates the two: what the IndexBox report actually says about the category, and what a buyer can and cannot conclude from it.
What is driving the nitric oxide supplements market?
IndexBox attributes the growth to three converging trends: rising participation in fitness and sports, an aging population seeking cardiovascular support and healthy blood flow, and growing consumer awareness of nitric oxide's role in exercise recovery and muscle pumps — awareness the report says is supported by scientific research. The category, once rooted in bodybuilding, has broadened to recreational athletes, active lifestylers, and older adults.
The report also names the constraints. Regulatory scrutiny of structure/function claims is intensifying, which raises compliance costs. Price competition from private label and low-cost imports pressures mid-tier margins. And consumer skepticism about the efficacy of some nitric oxide supplements is slowing repeat purchases. That last point is worth sitting with: even the industry-side analysis flags doubt about whether some products do what they claim.
What are nitric oxide supplements, and which ingredients are in them?
Per IndexBox, the category spans product formats based on L-arginine and L-citrulline, and the report cites growing consumer awareness of nitric oxide's role in exercise recovery and muscle pumps as a demand driver. The report does not evaluate the physiology behind these ingredients, and this article makes no claim about how they work in the body.
According to IndexBox, the market is also seeing demand for stimulant-free and naturally sourced formulations, personalized nutrition and dosage customization, and a move away from generic pre-workout blends toward specialized nitric oxide boosters.
How is the market expected to split by 2035?
IndexBox forecasts a bifurcation into two segments. One is a value-oriented mass segment, where private label and multi-ingredient blends compete on price per serving. The other is a premium segment built on clinically dosed, single-ingredient or patented formulations sold on benefit per dollar. E-commerce and direct-to-consumer channels are expected to keep gaining share in both.
Regionally, Asia-Pacific is projected to be the fastest-growing market, driven by urbanization, rising disposable incomes, and increasing health consciousness. North America and Europe remain significant, with growth from product innovation and premiumization. Latin America and the Middle East and Africa offer emerging opportunities, with regulatory and infrastructural challenges.
How big is the sports nutrition segment?
Sports nutrition and performance is the largest end-use sector, at an estimated 40% share, per IndexBox. Current demand is concentrated among bodybuilders, strength athletes, and serious gym-goers using pre-workout and intra-workout products. Through 2035, the report expects the segment to broaden as recreational athletes and active lifestylers join the buyer base. We covered a connected angle in Protein targets: how many grams per kilogram do athletes need?. For related coverage, see Protein targets: how many grams per kilogram do athletes need?.
The report also expects need states to fragment — endurance versus strength, for example — and says brands that demonstrate efficacy through third-party testing and transparent labeling will capture loyalty. For a reader, that is a signal about what to look for on a label, not a claim that any ingredient delivers a result. Anyone comparing supplement evidence across categories can see the same pattern in the research on how creatine monohydrate actually works in muscle: the strength of the claim depends entirely on the strength of the trials behind it. For related coverage, see How Creatine Monohydrate Actually Works in Muscle: The Evidence. We covered a connected angle in How Creatine Monohydrate Actually Works in Muscle: The Evidence.
What should a buyer take from this forecast?
Three things, all from the IndexBox report itself:
- Growth is expected, but so is skepticism. The report lists consumer doubt about efficacy as a real constraint on the category.
- Marketing language is under regulatory pressure. Stricter scrutiny of structure/function claims limits what brands can say, which makes transparent labeling and third-party testing the differentiators the report highlights.
- "Clinically dosed" is the premium segment's pitch. Whether a specific dose in a specific product is supported by evidence is a separate question the forecast does not answer.
The honest reading: the forecast tells you the category is commercially healthy through 2035. It does not tell you that a particular L-citrulline or L-arginine product will improve your workout. For decisions about what to take, the evidence base for each ingredient — and a qualified clinician — matters more than a market index.
Broader nutrition context for training decisions lives in the site's nutrition coverage, and readers weighing any supplement against food-first strategies may find the pre-training meal timing guide and the protein targets explainer useful comparisons.
This article is general information, not medical advice. Consult a qualified healthcare professional about your own situation.
